Cytarabine hydrochloride (MK-8242; SCH-900242; AC-1075; CHX-3311; Arabitin), the hydrochloride salt of cytarabine, is a pyrimidine nucleoside analog and antimetabolic anticancer agent with a modified sugar moiety.

Tegafur (formerly known as Fluorafur, FT-207, NSC-148958; Uftoral; UFT), a component of tegafur-uracil, is a chemotherapeutic anticancer prodrug of 5-FU (5-Fluorouracil, an anticancer drug) that is commonly used in the treatment of various cancers.

Metronidazole (trade names Flagyl, Metro, Trichopol, Vagilen), an imidazole-based and synthetic antibacterial and antiprotozoal drug belonging to the nitroimidazole class, is commonly used for the treatment of protozoa and other baterial infections.

E3330 (E-3330; E 3330; APX-3330; APX 3330; APX3330) is a potent, orally bioactive and selective APE1 (Ref-1, AP endonuclease 1) inhibitor with potential antitumor activity.

CRT0044876 (CRT-0044876; NSC 69877, 7-NO2-ICA; NSC-69877; CRT 0044876; NSC69877), an indole analog, is a potent and selective APE1 inhibitor with potential antitumor activity.

Gemcitabine HCl (formerly also known as LY-188011, NSC-613327; dFdC; dFdCyd; trade name: Gemzar), the hydrochloride salt of gemcitabine which is an antimetabolite anticancer drug, is a potent DNA synthesis inhibitor approved for cancer treatment.

Flunarizine 2HCl (formerly R-14950; KW3149; R14950; KW 3149; trade name Sibelium), the dihydrochloride salt form of Flunarizine, is a selective calcium entry/channel blocker with calmodulin binding properties and anti-histamine H1 activity.

Vidarabine (Ara-A; Adenine Arabinoside; 9-β-D-Arabinofuranosyladenine; Arabinofuranosyladenine) is an approved antiviral drug that interfers with the synthesis of viral DNA, and is mainly used to treat HSV and VZV: herpes simplex and varicella zoster viruses

Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense.

Brr2 inhibitor C9 (no formal name but also known as Brr2 Inhibitor 9 ) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2.